• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从人肾中纯化组织蛋白酶L与MHC II类相关恒定链片段的复合物。

Purification of the complex of cathepsin L and the MHC class II-associated invariant chain fragment from human kidney.

作者信息

Ogrinc T, Dolenc I, Ritonja A, Turk V

机构信息

Department of Biochemistry and Molecular Biology, Jozef Stefan Institute, Ljubljana, Slovenia.

出版信息

FEBS Lett. 1993 Dec 28;336(3):555-9. doi: 10.1016/0014-5793(93)80875-u.

DOI:10.1016/0014-5793(93)80875-u
PMID:8282126
Abstract

The complex of cathepsin L and the fragment of the MHC class II-associated invariant chain was purified from human kidney. M(r) of the complex, as determined by gel filtration, is about 40,000. Both components were identified by amino acid and sequence analyses. The bound invariant chain fragment is almost identical to the additional segment found in p41, but not in the p31 form of the invariant chain. The complex has significantly enhanced stability at neutral and slightly alkaline pH, and reduced proteolytic activity against the synthetic substrate Z-Phe-Arg-MCA compared to free cathepsin L. The complex exhibits no enzymatic activity against the protein substrate azocasein. For the first time, the invariant chain was found in a complex with a protein, which was not an MHC molecule.

摘要

组织蛋白酶L与MHC II类相关恒定链片段的复合物是从人肾脏中纯化得到的。通过凝胶过滤测定,该复合物的相对分子质量约为40,000。通过氨基酸和序列分析鉴定了两种组分。结合的恒定链片段与在p41中发现的额外片段几乎相同,但在恒定链的p31形式中不存在。与游离的组织蛋白酶L相比,该复合物在中性和微碱性pH下具有显著增强的稳定性,并且对合成底物Z-苯丙氨酸-精氨酸-甲基香豆素酰胺的蛋白水解活性降低。该复合物对蛋白质底物偶氮酪蛋白没有酶活性。首次发现恒定链与一种非MHC分子的蛋白质形成复合物。

相似文献

1
Purification of the complex of cathepsin L and the MHC class II-associated invariant chain fragment from human kidney.从人肾中纯化组织蛋白酶L与MHC II类相关恒定链片段的复合物。
FEBS Lett. 1993 Dec 28;336(3):555-9. doi: 10.1016/0014-5793(93)80875-u.
2
Crystal structure of MHC class II-associated p41 Ii fragment bound to cathepsin L reveals the structural basis for differentiation between cathepsins L and S.与组织蛋白酶L结合的MHC II类相关p41 Ii片段的晶体结构揭示了组织蛋白酶L和S之间差异的结构基础。
EMBO J. 1999 Feb 15;18(4):793-803. doi: 10.1093/emboj/18.4.793.
3
Simultaneous isolation of human kidney cathepsins B, H, L and C and their characterisation.人肾组织中组织蛋白酶B、H、L和C的同时分离及其特性研究
J Chromatogr B Biomed Appl. 1996 Jun 7;681(2):251-62. doi: 10.1016/0378-4347(95)00555-2.
4
The p41 fragment story.p41片段的故事。
IUBMB Life. 1999 Jul;48(1):7-12. doi: 10.1080/713803477.
5
Major histocompatibility complex class II-associated p41 invariant chain fragment is a strong inhibitor of lysosomal cathepsin L.主要组织相容性复合体II类相关p41恒定链片段是溶酶体组织蛋白酶L的强效抑制剂。
J Exp Med. 1996 Apr 1;183(4):1331-8. doi: 10.1084/jem.183.4.1331.
6
Proteolytically active complexes of cathepsin L and a cysteine proteinase inhibitor; purification and demonstration of their formation in vitro.组织蛋白酶L与一种半胱氨酸蛋白酶抑制剂的蛋白水解活性复合物;其体外纯化及形成的证明
Arch Biochem Biophys. 1992 May 1;294(2):623-9. doi: 10.1016/0003-9861(92)90734-e.
7
Purification and amino acid sequence of chicken liver cathepsin L.鸡肝组织组织蛋白酶L的纯化及氨基酸序列分析
Biochemistry. 1987 Sep 8;26(18):5689-95. doi: 10.1021/bi00392a017.
8
Inhibitory fragment from the p41 form of invariant chain can regulate activity of cysteine cathepsins in antigen presentation.来自恒定链p41形式的抑制性片段可在抗原呈递过程中调节半胱氨酸组织蛋白酶的活性。
J Biol Chem. 2008 May 23;283(21):14453-60. doi: 10.1074/jbc.M801283200. Epub 2008 Mar 24.
9
A new purification procedure of human kidney cathepsin H, its properties and kinetic data.人肾组织组织蛋白酶H的一种新纯化方法、其性质及动力学数据。
Biol Chem Hoppe Seyler. 1988 May;369 Suppl:175-83.
10
Bovine cathepsins S and L: isolation and amino acid sequences.牛组织蛋白酶S和L:分离与氨基酸序列
Biol Chem Hoppe Seyler. 1992 Jul;373(7):407-12. doi: 10.1515/bchm3.1992.373.2.407.

引用本文的文献

1
Host-Directed Therapies Based on Protease Inhibitors to Control and HIV Coinfection.基于蛋白酶抑制剂的宿主导向疗法以控制结核与HIV合并感染。
Microorganisms. 2025 Apr 30;13(5):1040. doi: 10.3390/microorganisms13051040.
2
Cathepsins and Their Endogenous Inhibitors in Host Defense During and HIV Infection.组织蛋白酶及其内源性抑制剂在细菌感染和 HIV 感染期间的宿主防御作用。
Front Immunol. 2021 Aug 4;12:726984. doi: 10.3389/fimmu.2021.726984. eCollection 2021.
3
The Role of Cysteine Peptidases in Hematopoietic Stem Cell Differentiation and Modulation of Immune System Function.
半胱氨酸肽酶在造血干细胞分化及免疫系统功能调节中的作用
Front Immunol. 2021 Jul 15;12:680279. doi: 10.3389/fimmu.2021.680279. eCollection 2021.
4
Cathepsin S: investigating an old player in lung disease pathogenesis, comorbidities, and potential therapeutics.组织蛋白酶 S:探究肺部疾病发病机制、合并症和潜在治疗方法中的一个老角色。
Respir Res. 2020 May 12;21(1):111. doi: 10.1186/s12931-020-01381-5.
5
The biological function and significance of CD74 in immune diseases.CD74在免疫疾病中的生物学功能及意义。
Inflamm Res. 2017 Mar;66(3):209-216. doi: 10.1007/s00011-016-0995-1. Epub 2016 Oct 17.
6
Exogenous Thyropin from p41 Invariant Chain Diminishes Cysteine Protease Activity and Affects IL-12 Secretion during Maturation of Human Dendritic Cells.来自p41恒定链的外源性促甲状腺素在人树突状细胞成熟过程中降低半胱氨酸蛋白酶活性并影响白细胞介素-12的分泌。
PLoS One. 2016 Mar 9;11(3):e0150815. doi: 10.1371/journal.pone.0150815. eCollection 2016.
7
CD74 in Kidney Disease.肾病中的CD74
Front Immunol. 2015 Sep 23;6:483. doi: 10.3389/fimmu.2015.00483. eCollection 2015.
8
Cysteine cathepsins: from structure, function and regulation to new frontiers.半胱氨酸组织蛋白酶:从结构、功能与调控到新前沿领域
Biochim Biophys Acta. 2012 Jan;1824(1):68-88. doi: 10.1016/j.bbapap.2011.10.002. Epub 2011 Oct 12.
9
The crystal structures of two salivary cystatins from the tick Ixodes scapularis and the effect of these inhibitors on the establishment of Borrelia burgdorferi infection in a murine model.两种来自硬蜱Ixodes scapularis 的唾液cystatins 的晶体结构,以及这些抑制剂对在小鼠模型中建立 Borrelia burgdorferi 感染的影响。
Mol Microbiol. 2010 Jul;77(2):456-70. doi: 10.1111/j.1365-2958.2010.07220.x. Epub 2010 Jun 1.
10
Inhibitory p41 isoform of invariant chain and its potential target enzymes cathepsins L and H in distinct populations of macrophages in human lymph nodes.人淋巴结中不同巨噬细胞群体中恒定链的抑制性p41亚型及其潜在靶酶组织蛋白酶L和H
Immunology. 2004 Jul;112(3):378-85. doi: 10.1111/j.1365-2567.2004.01879.x.